MY192896A - N-[ (2 ` r) -2? ? deoxy-2? ?fluoro-2? ?methyl-p-phenyl-5? ?uridylyl] ?l-alanine 1-methylethyl ester and process for its production - Google Patents

N-[ (2 ` r) -2? ? deoxy-2? ?fluoro-2? ?methyl-p-phenyl-5? ?uridylyl] ?l-alanine 1-methylethyl ester and process for its production

Info

Publication number
MY192896A
MY192896A MYPI2016701103A MYPI2016701103A MY192896A MY 192896 A MY192896 A MY 192896A MY PI2016701103 A MYPI2016701103 A MY PI2016701103A MY PI2016701103 A MYPI2016701103 A MY PI2016701103A MY 192896 A MY192896 A MY 192896A
Authority
MY
Malaysia
Prior art keywords
uridylyl
deoxy
alanine
fluoro
phenyl
Prior art date
Application number
MYPI2016701103A
Inventor
S Ross Bruce
Joseph Sofia Michael
Reddy Pamulapati Ganapati
Rachakonda Suguna
Hai-Ren Zhang
Byoung-Kwon Chun
Peiyuan Wang
Original Assignee
Gilead Pharmasset Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Pharmasset Llc filed Critical Gilead Pharmasset Llc
Priority to MYPI2016701103A priority Critical patent/MY192896A/en
Publication of MY192896A publication Critical patent/MY192896A/en

Links

Abstract

Disclosed herein are nucleoside phosphoramidates and their use as agents for treating viral diseases. These compounds are inhibitors of RNA-dependent 5 RNA viral replication and are useful as inhibitors of HCV NS5B polymerase, as inhibitors of HCV replication and for treatment of hepatitis C infection in mammals.
MYPI2016701103A 2010-05-20 2010-05-20 N-[ (2 ` r) -2? ? deoxy-2? ?fluoro-2? ?methyl-p-phenyl-5? ?uridylyl] ?l-alanine 1-methylethyl ester and process for its production MY192896A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2016701103A MY192896A (en) 2010-05-20 2010-05-20 N-[ (2 ` r) -2? ? deoxy-2? ?fluoro-2? ?methyl-p-phenyl-5? ?uridylyl] ?l-alanine 1-methylethyl ester and process for its production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2016701103A MY192896A (en) 2010-05-20 2010-05-20 N-[ (2 ` r) -2? ? deoxy-2? ?fluoro-2? ?methyl-p-phenyl-5? ?uridylyl] ?l-alanine 1-methylethyl ester and process for its production

Publications (1)

Publication Number Publication Date
MY192896A true MY192896A (en) 2022-09-14

Family

ID=83444707

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2016701103A MY192896A (en) 2010-05-20 2010-05-20 N-[ (2 ` r) -2? ? deoxy-2? ?fluoro-2? ?methyl-p-phenyl-5? ?uridylyl] ?l-alanine 1-methylethyl ester and process for its production

Country Status (1)

Country Link
MY (1) MY192896A (en)

Similar Documents

Publication Publication Date Title
MY176918A (en) N- [ (2 ' r) -2' -deoxy-2' -fluoro-2' -methyl-p-phenyl-5' -uridylyl] - l-alanine 1-methylethyl ester and process for its production
MX350725B (en) Nucleoside phosphoramidates.
EP2609923A3 (en) Nucleoside Phosphoramidates
MX2011007364A (en) Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections.
WO2008085508A3 (en) Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
WO2007095269A3 (en) Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
CY1111342T1 (en) ANASTALEASE NUCLEOSIDE TOY HCV (US C virus)
EP2120565A4 (en) Nucleoside cyclic phosphoramidates for the treatment of rna-dependent rna viral infection
EA201391519A1 (en) 2'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHODS OF THEIR USE FOR THE TREATMENT OF VIRAL DISEASES
NZ616512A (en) Modulation of hepatitis b virus (hbv) expression
ATE505475T1 (en) NUCLEOSIDE DERIVATIVES AS INHIBITORS OF VIRAL POLYMERASES
ATE507293T1 (en) CONSERVED HBV AND HCV SEQUENCES SUITABLE FOR GENE SILENCING
NI200700043A (en) INHIBITORS OF RNA-DEPENDENT RNA POLYMERASE OF HEPATITIS C VIRUS AND COMPOSITIONS AND TREATMENTS USING THEM.
BR112012015951A2 (en) 4 azido nucleosides as anti-hcv compounds
EA202191537A1 (en) COMPOSITIONS AND METHODS FOR INHIBITION OF HEPATITIS B VIRUS GENE EXPRESSION
EA201491180A1 (en) 4'-AZIDO, 3'-FLUORINE-SUBSTITUTED DERIVATIVES OF NUCLEOSIDES AS AN INHIBITORS OF REPLICATION OF RNA HEPATITIS C VIRUS
MY192896A (en) N-[ (2 ` r) -2? ? deoxy-2? ?fluoro-2? ?methyl-p-phenyl-5? ?uridylyl] ?l-alanine 1-methylethyl ester and process for its production
BR112013000245A2 (en) heterocyclic antiviral compounds
CY1116976T1 (en) CRYSTALL 2 - (((S) - (((2R, 3R, 4R, 5R) -5- (2,4-DIOXO-3,4-DIPPYPYRIMIDIN-1- (2H) -YL) -4-fluoro-3) -HYDROXY-4-METHYLTETRAHODROFURAN-2-YL) METHOXY) (FANOXY) PHOSPHORYL) AMINO) PROPANIC (S) -ISOPROPYL
CL2009000505A1 (en) Compounds derived from nitrogenous tricycles, inhibitors of viral DNA and RNA polymerases; pharmaceutical composition comprising them; and use in the treatment of viral infections and cancer.
DOP2005000165A (en) INHIBITORS OF THE RNA-DEPENDENT RNA POLYMERASE OF THE HEPATITIS C VIRUS AND COMPOSITIONS AND TREATMENTS USING THEM
CU23533A3 (en) INHIBITORS OF THE RNA-DEPENDENT RNA POLYMERASE OF THE HEPATITIS C VIRUS AND COMPOSITIONS AND TREATMENTS USING THEM
UA106081C2 (en) Heterocyclic antiviral compounds
UA110976C2 (en) SUBSTITUTED ALIPHANES, CYCLOPHANS, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALOCENES, SUITABLE FOR USE IN THE TREATMENT OF HCV INFECTION